FELIX study results reveal obe-cel's potential in relapsed B-cell ALL, achieving 77% remission with low severe toxicity, enhancing CAR T-cell therapy outcomes.
Remdesivir treatment reduces the risk for 30-day COVID-19-related hospital readmission among all patients discharged alive from initial hospitalization.
A urethral swab screens for many types of infection. A provider quickly collects a sample by inserting a special Q-tip into the tip of the penis. Learn more.